查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1713646

2025年全球定期健康体检市场报告

Routine Health Screening Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年定期健康体检市场规模将强劲成长。到 2029 年，这一数字将成长至 777.6 亿美元，年复合成长率（CAGR）为 7.4%。预测期内的成长归因于个人化医疗的日益普及、对慢性病管理的日益关注、新兴市场的医疗保健覆盖面的扩大、医疗保健支出的增加以及公共和私人对预防性医疗保健计划的投资的增加。预测期内的关键趋势包括整合人工智慧以提高诊断准确性、透过远端医疗平台扩展健康检查服务、由于公共卫生倡议而日益关注预防性医疗保健、透过行动医疗应用程式和数位健康平台增强病人参与以及开发基于先进生物标誌物的筛检技术。

预计预防性医疗保健意识的提高将在未来推动常规筛检市场的发展。预防性保健包括透过早期发现、改变生活方式和主动干预来预防疾病和健康状况的实践和措施。由于预防性医疗保健具有早期发现疾病、改善健康结果和降低成本等优势，随着公众教育的加强和医学的进步，人们的认识不断提高。定期健康检查有助于预防性医疗保健，可及早发现潜在的健康问题，从而及时干预并降低严重的风险。例如，英国国家医疗服务体系（NHS）在2023年5月报告称，2023年3月共进行了2,302,400次诊断测试，比2022年3月增加了223,100次。截至2023年3月底，等待关键诊断测试的患者人数为1,628,300人，比2022年3月增加了59,400人。这表明，人们对预防性医疗保健的认识不断提高，正在推动定期健康体检市场的成长。

为了获得竞争优势，常规健康体检市场的主要企业正专注于开发肺癌筛检测试等先进的解决方案。这些测试的目的是在高风险族群中及早发现肺癌，甚至在症状出现之前。例如，2023 年 10 月，美国诊断技术公司 DELFI Diagnostics, Inc. 推出了 FirstLook Lung 测试，这是一项旨在改善肺癌筛检的创新血液检查。 FirstLook Lung 使用片段组体学分析血液检体中的无细胞 DNA (cfDNA) 模式，并采用先进的机器学习来区分癌症和非癌症模式。此测试的阴性预测值 (NPV) 为 99.7%，可准确识别可能的肺癌，同时减少不必要的低剂量 CT (LDCT) 扫描的需要。 FirstLook Lung 将被整合到常规血液检测中，以提高筛检率，特别是在服务不足的人群中。它还具有可扩展的全基因组机器学习平台，有可能扩展到全球其他癌症和治疗监测。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球定期健康检视PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球定期健康体检市场：成长率分析
  • 全球定期健康体检市场表现：规模与成长，2019-2024年
  • 全球定期健康体检市场预测：2024-2029 年及 2034 年规模与成长
  • 全球常规体检总目标市场（TAM）

第六章市场区隔

  • 全球定期健康体检市场（按检查类型、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 血糖值检测
  • 肾功能检查
  • 骨轮廓测试
  • 电解质测试
  • 肝功能检查
  • 血脂检测
  • 其他测试类型
  • 全球定期健康体检市场（依样本类型、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 血
  • 尿
  • 血清
  • 唾液
  • 其他样本类型
  • 全球定期体检市场：依技术、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 定量聚合酵素链锁反应（QPCR）
  • 定量萤光原位杂合反应（Q-FISH）
  • 免疫检测
  • 医学影像
  • 单端粒长度分析（STELA）
  • 其他技术
  • 全球常规健康体检市场依样本采集地点、表现及预测，2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 住宅
  • 诊断实验室
  • 办公室
  • 其他样本采集地点
  • 全球定期健康体检市场依血糖值测试类型、表现及预测细分，2019-2024 年、2024-2029 年、2034 年
  • 空腹血糖值检测
  • HbA1c 检测
  • 持续血糖监测
  • 全球定期健康体检市场依肾功能检查类型、绩效及预测细分，2019-2024 年、2024-2029 年、2034 年
  • 血清肌酸酐检测
  • 血中尿素氮（BUN）检测
  • 尿液检查
  • 全球定期健康体检市场骨骼轮廓测试细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 血清钙检测
  • 磷酸盐测试
  • 骨骼密度（BMD）测试
  • 全球定期健康体检市场电解质测试细分（按类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 血清钠检测
  • 血清钾检测
  • 血清氯化物检测
  • 全球定期体检市场按肝功能检查类型、表现及预测的细分情况（2019-2024 年、2024-2029 年及 2034 年）
  • 丙胺基转移酶（ALT）检测
  • 天门冬胺基转移酶（AST）检测
  • 胆红素检测
  • 全球常规健康体检市场血脂检测细分类型、表现及预测（2019-2024 年、2024-2029 年、2034 年）
  • 总胆固醇检测
  • 低密度脂蛋白（LDL）检测
  • 高密度脂蛋白（HDL）检测
  • 全球定期健康体检市场、其他检查类型细分、按类型、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 甲状腺功能检查
  • 全血球计数（CBC）
  • 前列腺特异性抗原（PSA）检测

第七章 区域和国家分析

  • 全球定期健康体检市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球定期健康体检市场：依国家、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 定期健康体检市场：竞争格局
  • 定期健康体检市场：公司简介
    • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
    • Laboratory Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Eurofins Scientific SE
  • Agilent Technologies Inc.
  • Sonic Healthcare Limited
  • Hologic Inc.
  • Illumina Inc.
  • SYNLAB International GmbH
  • Sysmex Corporation
  • QIAGEN NV
  • Exact Sciences Corporation
  • RadNet Inc.
  • Opko Health Inc.
  • UNILABS
  • Amedes Holding GmbH
  • Natera Inc.
  • Grail Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年常规健康体检市场：提供新机会的国家
  • 2029年常规健康体检市场：细分领域蕴藏新机会
  • 2029年常规健康体检市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r33548

Routine health screening involves regular medical tests and check-ups designed to detect potential health issues before symptoms arise. These screenings are essential for monitoring overall health, identifying risk factors, and preventing serious conditions such as heart disease, diabetes, or cancer. Recommendations for screenings are typically based on factors such as age, gender, and health history, and they play a crucial role in maintaining long-term health and well-being.

The main types of routine health screenings include blood glucose tests, kidney function tests, bone profile tests, electrolyte tests, liver function tests, lipid profile tests, and others. A blood glucose test measures the level of glucose (sugar) in the blood to detect or manage diabetes. Samples for these tests can be obtained from blood, urine, serum, saliva, and other sources. Technologies used in these screenings include quantitative polymerase chain reaction (QPCR), quantitative fluorescence in situ hybridization (Q-FISH), immunoassays, medical imaging, single telomere length analysis (STELA), and others. Sample collection sites for these tests may include hospitals, homes, diagnostic laboratories, offices, and other locations.

The routine health screening market research report is one of a series of new reports from The Business Research Company that provides routine health screening market statistics, including routine health screening industry global market size, regional shares, competitors with a routine health screening market share, detailed routine health screening market segments, market trends and opportunities, and any further data you may need to thrive in the routine health screening industry. This routine health screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The routine health screening market size has grown strongly in recent years. It will grow from $54.28 billion in 2024 to $58.45 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to increasing awareness of preventive healthcare, the rising prevalence of chronic diseases, growing government initiatives for early disease detection, the aging global population, and the expansion of healthcare infrastructure.

The routine health screening market size is expected to see strong growth in the next few years. It will grow to $77.76 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to the growing adoption of personalized medicine, increasing focus on chronic disease management, expansion of healthcare access in emerging markets, rising healthcare spending, and greater public and private investment in preventive health programs. Major trends in the forecast period include the integration of artificial intelligence for improved diagnostic accuracy, expansion of health screening services through telemedicine platforms, heightened focus on preventive care driven by public health initiatives, enhanced patient engagement through mobile health apps and digital health platforms, and the development of advanced biomarker-based screening technologies.

The growing awareness of preventive healthcare is expected to boost the routine health screenings market in the future. Preventive healthcare involves practices and measures aimed at preventing diseases and health conditions through early detection, lifestyle changes, and proactive interventions. Increased awareness of preventive healthcare is due to its advantages in early disease detection, improved health outcomes, and cost savings, driven by enhanced public education and medical advancements. Routine health screenings support preventive healthcare by identifying potential health issues early, enabling timely interventions, and reducing the risk of severe diseases. For example, the National Health Service (NHS) reported in May 2023 that 2,302,400 diagnostic tests were conducted in March 2023, an increase of 223,100 tests compared to March 2022. By the end of March 2023, the number of patients waiting for a key diagnostic test had risen to 1,628,300, an increase of 59,400 from March 2022. This indicates that the rising awareness of preventive healthcare is driving growth in the routine health screenings market.

Leading companies in the routine health screenings market are focusing on developing advanced solutions, such as lung cancer screening tests, to gain a competitive advantage. These tests are designed to detect lung cancer early in individuals at high risk, even before symptoms appear. For instance, in October 2023, DELFI Diagnostics, Inc., a U.S.-based diagnostic technology company, launched the FirstLook Lung test, an innovative blood test aimed at improving lung cancer screening. FirstLook Lung uses fragmentomics to analyze patterns in cell-free DNA (cfDNA) from blood samples and employs advanced machine learning to distinguish between cancerous and non-cancerous patterns. With a 99.7% negative predictive value (NPV), the test accurately identifies potential lung cancer cases while reducing the need for unnecessary low-dose CT (LDCT) scans. FirstLook Lung is integrated into routine blood tests to improve screening rates, especially among underserved populations, and features a scalable whole-genome machine-learning platform that could potentially expand into other cancers and treatment monitoring globally.

In March 2024, Laboratory Corporation of America Holdings, a U.S.-based healthcare and diagnostics company, acquired BioReference Health from OPKO Health, Inc. for $237.5 million. This acquisition is intended to enhance Labcorp's capabilities and access in routine health screening. BioReference Health, a U.S.-based diagnostic laboratory company, offers testing services, including routine health screenings, oncology, urology, and reproductive and women's health tests.

Major companies operating in the routine health screening market are Roche Holding AG, Thermo Fisher Scientific Inc., Siemens Healthineers, Laboratory Corporation, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Sonic Healthcare Limited, Hologic Inc., Illumina Inc., SYNLAB International GmbH, Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, RadNet Inc., Opko Health Inc., UNILABS, Amedes Holding GmbH, Natera Inc., Grail Inc., Trinity Biotech PLC, Cerba HealthCare S.A.S., Quidel Corporation, Innova Medical Group

North America was the largest region in the routine health screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the routine health screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the routine health screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The routine health screening market consists of revenues earned by entities by providing services such as health assessments, screening procedures, consultations, telehealth screenings, and corporate wellness programs. The market value includes the value of related goods sold by the service provider or included within the service offering. The routine health screening also includes sales of diagnostic test kits, medical devices, wearable health devices, and laboratory testing supplies. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Routine Health Screening Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on routine health screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for routine health screening ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The routine health screening market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Test Type: Blood Glucose Test; Kidney Function Test; Bone Profile Test; Electrolyte Test; Liver Function Test; Lipid Profile Test; Other Test Types
  • 2) By Sample Type: Blood; Urine; Serum; Saliva; Other Sample Types
  • 3) By Technology: Quantitative Polymerase Chain Reaction (QPCR); Quantitative Fluorescence In Situ Hybridization (Q-FISH); Immunoassays; Medical Imaging; Single Telomere Length Analysis (STELA); Other Technologies
  • 4) By Sample Collection Sites: Hospitals; Homes; Diagnostic Laboratories; Offices; Other Sample Collection Sites
  • Subsegments:
  • 1) By Blood Glucose Test: Fasting Blood Glucose Test; HbA1c Test; Continuous Glucose Monitoring
  • 2) By Kidney Function Test: Serum Creatinine Test; Blood Urea Nitrogen (BUN) Test; Urinalysis
  • 3) By Bone Profile Test: Serum Calcium Test; Phosphate Test; Bone Mineral Density (BMD) Test
  • 4) By Electrolyte Test: Serum Sodium Test; Serum Potassium Test; Serum Chloride Test
  • 5) By Liver Function Test: Alanine Aminotransferase (ALT) Test; Aspartate Aminotransferase (AST) Test; Bilirubin Test
  • 6) By Lipid Profile Test: Total Cholesterol Test; Low-Density Lipoprotein (LDL) Test; High-Density Lipoprotein (HDL) Test
  • 7) By Other Test Types: Thyroid Function Test; Complete Blood Count (CBC); Prostate-Specific Antigen (PSA) Test
  • Companies Mentioned: Roche Holding AG; Thermo Fisher Scientific Inc.; Siemens Healthineers; Laboratory Corporation; Quest Diagnostics Incorporated
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Routine Health Screening Market Characteristics

3. Routine Health Screening Market Trends And Strategies

4. Routine Health Screening Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Routine Health Screening Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Routine Health Screening PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Routine Health Screening Market Growth Rate Analysis
  • 5.4. Global Routine Health Screening Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Routine Health Screening Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Routine Health Screening Total Addressable Market (TAM)

6. Routine Health Screening Market Segmentation

  • 6.1. Global Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Glucose Test
  • Kidney Function Test
  • Bone Profile Test
  • Electrolyte Test
  • Liver Function Test
  • Lipid Profile Test
  • Other Test Types
  • 6.2. Global Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood
  • Urine
  • Serum
  • Saliva
  • Other Sample Types
  • 6.3. Global Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Quantitative Polymerase Chain Reaction (QPCR)
  • Quantitative Fluorescence In Situ Hybridization (Q-FISH)
  • Immunoassays
  • Medical Imaging
  • Single Telomere Length Analysis (STELA)
  • Other Technologies
  • 6.4. Global Routine Health Screening Market, Segmentation By Sample Collection Sites, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Homes
  • Diagnostic Laboratories
  • Offices
  • Other Sample Collection Sites
  • 6.5. Global Routine Health Screening Market, Sub-Segmentation Of Blood Glucose Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fasting Blood Glucose Test
  • HbA1c Test
  • Continuous Glucose Monitoring
  • 6.6. Global Routine Health Screening Market, Sub-Segmentation Of Kidney Function Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Serum Creatinine Test
  • Blood Urea Nitrogen (BUN) Test
  • Urinalysis
  • 6.7. Global Routine Health Screening Market, Sub-Segmentation Of Bone Profile Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Serum Calcium Test
  • Phosphate Test
  • Bone Mineral Density (BMD) Test
  • 6.8. Global Routine Health Screening Market, Sub-Segmentation Of Electrolyte Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Serum Sodium Test
  • Serum Potassium Test
  • Serum Chloride Test
  • 6.9. Global Routine Health Screening Market, Sub-Segmentation Of Liver Function Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Alanine Aminotransferase (ALT) Test
  • Aspartate Aminotransferase (AST) Test
  • Bilirubin Test
  • 6.10. Global Routine Health Screening Market, Sub-Segmentation Of Lipid Profile Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Total Cholesterol Test
  • Low-Density Lipoprotein (LDL) Test
  • High-Density Lipoprotein (HDL) Test
  • 6.11. Global Routine Health Screening Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Thyroid Function Test
  • Complete Blood Count (CBC)
  • Prostate-Specific Antigen (PSA) Test

7. Routine Health Screening Market Regional And Country Analysis

  • 7.1. Global Routine Health Screening Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Routine Health Screening Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Routine Health Screening Market

  • 8.1. Asia-Pacific Routine Health Screening Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Routine Health Screening Market

  • 9.1. China Routine Health Screening Market Overview
  • 9.2. China Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Routine Health Screening Market

  • 10.1. India Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Routine Health Screening Market

  • 11.1. Japan Routine Health Screening Market Overview
  • 11.2. Japan Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Routine Health Screening Market

  • 12.1. Australia Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Routine Health Screening Market

  • 13.1. Indonesia Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Routine Health Screening Market

  • 14.1. South Korea Routine Health Screening Market Overview
  • 14.2. South Korea Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Routine Health Screening Market

  • 15.1. Western Europe Routine Health Screening Market Overview
  • 15.2. Western Europe Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Routine Health Screening Market

  • 16.1. UK Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Routine Health Screening Market

  • 17.1. Germany Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Routine Health Screening Market

  • 18.1. France Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Routine Health Screening Market

  • 19.1. Italy Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Routine Health Screening Market

  • 20.1. Spain Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Routine Health Screening Market

  • 21.1. Eastern Europe Routine Health Screening Market Overview
  • 21.2. Eastern Europe Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Routine Health Screening Market

  • 22.1. Russia Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Routine Health Screening Market

  • 23.1. North America Routine Health Screening Market Overview
  • 23.2. North America Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Routine Health Screening Market

  • 24.1. USA Routine Health Screening Market Overview
  • 24.2. USA Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Routine Health Screening Market

  • 25.1. Canada Routine Health Screening Market Overview
  • 25.2. Canada Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Routine Health Screening Market

  • 26.1. South America Routine Health Screening Market Overview
  • 26.2. South America Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Routine Health Screening Market

  • 27.1. Brazil Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Routine Health Screening Market

  • 28.1. Middle East Routine Health Screening Market Overview
  • 28.2. Middle East Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Routine Health Screening Market

  • 29.1. Africa Routine Health Screening Market Overview
  • 29.2. Africa Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Routine Health Screening Market Competitive Landscape And Company Profiles

  • 30.1. Routine Health Screening Market Competitive Landscape
  • 30.2. Routine Health Screening Market Company Profiles
    • 30.2.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Laboratory Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis

31. Routine Health Screening Market Other Major And Innovative Companies

  • 31.1. Eurofins Scientific SE
  • 31.2. Agilent Technologies Inc.
  • 31.3. Sonic Healthcare Limited
  • 31.4. Hologic Inc.
  • 31.5. Illumina Inc.
  • 31.6. SYNLAB International GmbH
  • 31.7. Sysmex Corporation
  • 31.8. QIAGEN N.V.
  • 31.9. Exact Sciences Corporation
  • 31.10. RadNet Inc.
  • 31.11. Opko Health Inc.
  • 31.12. UNILABS
  • 31.13. Amedes Holding GmbH
  • 31.14. Natera Inc.
  • 31.15. Grail Inc.

32. Global Routine Health Screening Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Routine Health Screening Market

34. Recent Developments In The Routine Health Screening Market

35. Routine Health Screening Market High Potential Countries, Segments and Strategies

  • 35.1 Routine Health Screening Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Routine Health Screening Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Routine Health Screening Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
  • 250423_r33548_Routine_Health_Screening_GMR_2025